Skip to main navigation
  • Therapeutic Focus
    • Genetic Disorders
    • Oncology
    • Additional Resources
      • US Expanded Access Policy
  • About PTC
    • Our Science
      • Nonsense Readthrough
      • Alternative Splicing Program
      • Transcript Regulators
    • Our History
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
    • Collaborations
    • Contact Us
    • Locations
    • PTC STRIVE Awards Program
      • Program Overview
      • Review Committee
      • STRIVE for DMD
      • FAQs
  • Pipeline
    • Ataluren (Translarna™)
      • Ataluren Publications
      • Ataluren FAQ
    • BMI1 - PTC596
    • SMA Program – RG7916
    • Clinical Trials: ataluren
      • DMD Clinical Trial Overview
  • Investors

    Investor header menu

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Report and Proxy
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact Us
PTC Therapeutics
  • Therapeutic Focus
    • Genetic Disorders
    • Oncology
    • Additional Resources
      • US Expanded Access Policy
  • About PTC
    • Our Science
      • Nonsense Readthrough
      • Alternative Splicing Program
      • Transcript Regulators
    • Our History
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
    • Collaborations
    • Contact Us
    • Locations
    • PTC STRIVE Awards Program
      • Program Overview
      • Review Committee
      • STRIVE for DMD
      • FAQs
  • Pipeline
    • Ataluren (Translarna™)
      • Ataluren Publications
      • Ataluren FAQ
    • BMI1 - PTC596
    • SMA Program – RG7916
    • Clinical Trials: ataluren
      • DMD Clinical Trial Overview
  • Investors

    Investor header menu

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Report and Proxy
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact Us

Financials & Filings

Financials & Filings

Annual Reports
TitleView
2017 Annual Report
2017 Annual Report 5.1 MB
2016 Annual Report
2016 Annual Report 3.1 MB
Proxy Statements
TitleView
2018 Proxy Statement
2018 Proxy Statement 1.8 MB
2017 Proxy Statement
2017 Proxy Statement 1 MB

Form 10-K

Filing date View
Mar 6, 2014 View HTML
0001047469-14-001914.pdf
0001047469-14-001914.xls
EX-101.INS - EX-101.INS
Apr 29, 2014 View HTML

Form 10-Q

Filing date View
Aug 13, 2013 View HTML
0001104659-13-062994.pdf
0001104659-13-062994.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 14, 2013 View HTML
0001104659-13-084831.pdf
0001104659-13-084831.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
    • SEC Filings
  • Annual Report and Proxy
  • Stock Information
  • Investor FAQs
  • Contact Us

Shareholder Tools

Shareholder Tools

Printed Materials
Email Alerts
Downloads
RSS
Print
Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS
SitemapContactLocationcareers © 2019 PTC Therapeutics. All rights reserved.